Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)
Ceribell's (CBLL) quarterly Liabilities and Shareholders Equity came in at $178.1 million in Q1 2026, down 16.58% YoY from $213.5 million in Q1 2025, and down 9.05% on a QoQ basis from $195.8 million in Q4 2025.
Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $178.1 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 16.58% year-over-year to $178.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $781.1 million (up 60.74% YoY) and the FY2025 annual result came in at $195.8 million, down 13.14% from the prior year.
- Liabilities and Shareholders Equity fell to $178.1 million in Q1 2026, from $195.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $225.4 million in Q4 2024 to a low of $47.1 million in Q3 2024.
- A 4-year average of $165.7 million and a median of $197.7 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 323.99% — and 2026, when it decreased 16.58%.
- Tracing CBLL's Liabilities and Shareholders Equity over 4 years: stood at $58.9 million in 2023, then soared by 282.56% to $225.4 million in 2024, then decreased by 13.14% to $195.8 million in 2025, then dropped by 9.05% to $178.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $178.1 million (Q1 2026), $195.8 million (Q4 2025), and $199.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Ceribell | 923.42 Mn | 794.16 Mn | 25.94 Mn | 166.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 166.35 Mn |
| Mar 31, 2026 | 178.08 Mn |
| Dec 31, 2025 | 195.80 Mn |
| Sep 30, 2025 | 199.53 Mn |
| Jun 30, 2025 | 207.69 Mn |
| Mar 31, 2025 | 213.47 Mn |
| Dec 31, 2024 | 225.41 Mn |
| Sep 30, 2024 | 47.06 Mn |
| Dec 31, 2023 | 58.92 Mn |